Zentalis Pharmaceuticals: Late Stage, Lots Of Cash, Crushed By The Market

Core Insights - Zentalis Pharmaceuticals (ZNTL) is a microcap biotech company focused on developing targeted therapies for DNA damage repair [1] - The company has undergone a recent restructuring and is now concentrating all efforts on the late-stage development of a single drug [1] Company Overview - Zentalis Pharmaceuticals specializes in targeted therapies within the DNA damage repair sector [1] - The company is currently in a pivotal phase, emphasizing the late-stage development of one specific drug following a strategic restructuring [1]